These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7491174)
1. Superiority of SPET to planar imaging in the detection of colorectal carcinomas with 111In monoclonal antibodies. Nabi HA; Erb DA; Cronin VR Nucl Med Commun; 1995 Aug; 16(8):631-9. PubMed ID: 7491174 [TBL] [Abstract][Full Text] [Related]
2. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity. Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunodetection of colorectal carcinoma with 111In-labelled monoclonal antibody IVP ZCE 025 (a tissue culture-produced anti-CEA MAb). Abdel-Nabi H; Doerr RJ; Evans NH; Farrell EE; Chan HW; Balu D; Gona J; Schweighardt S Nucl Med Commun; 1994 Feb; 15(2):81-93. PubMed ID: 8170642 [TBL] [Abstract][Full Text] [Related]
4. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer. Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756 [TBL] [Abstract][Full Text] [Related]
7. [Indium 111-labeled antibodies in the detection of colorectal carcinoma]. Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496 [TBL] [Abstract][Full Text] [Related]
8. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer. Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688 [TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature. Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876 [TBL] [Abstract][Full Text] [Related]
12. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases. Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120 [TBL] [Abstract][Full Text] [Related]
13. Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence. Liehn JC; Loboguerrero A; Pérault C; Demange L Eur J Nucl Med; 1992; 19(3):186-94. PubMed ID: 1572383 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials. Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662 [TBL] [Abstract][Full Text] [Related]
15. Volume rendering and bicolour scale in double isotope studies: application to immunoscintigraphy and bone landmarking. Loboguerrero A; Pérault C; Liehn JC Eur J Nucl Med; 1992; 19(3):201-4. PubMed ID: 1572385 [TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3. Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429 [TBL] [Abstract][Full Text] [Related]
17. Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. Chetanneau A; Barbet J; Peltier P; Le Doussal JM; Gruaz-Guyon A; Bernard AM; Resche I; Rouvier E; Bourguet P; Delaage M Nucl Med Commun; 1994 Dec; 15(12):972-80. PubMed ID: 7715897 [TBL] [Abstract][Full Text] [Related]
18. The value of SPET/CT in chronic osteomyelitis. Horger M; Eschmann SM; Pfannenberg C; Storek D; Dammann F; Vonthein R; Claussen CD; Bares R Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1665-73. PubMed ID: 14523585 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis. Corbisiero RM; Yamauchi DM; Williams LE; Esteban JM; Odom-Maryon T; Beatty JD Cancer Res; 1991 Oct; 51(20):5704-11. PubMed ID: 1913688 [TBL] [Abstract][Full Text] [Related]
20. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management? Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]